Release Date: 13/04/21 11:06 Summary: Initial Director's Interest Notice Price Sensitive: No Download Document 192.05KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%